fluoxetine has been researched along with Hypotension, Postural in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine appears to cause a low incidence of adverse cardiac effects." | 5.28 | Fluoxetine-induced bradycardia and syncope in two patients. ( Ellison, JM; Ely, E; Milofsky, JE, 1990) |
| "All patients demonstrated orthostatic hypotension (20 mm Hg or greater decline in systolic blood pressure) associated with symptoms (eg, dizziness, vertigo, near syncope) in the baseline state." | 2.67 | Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. ( Grubb, BP; Kosinski, D; Lorton, M; Madu, E; Samoil, D; Wolfe, D, 1994) |
| "Fluoxetine appears to cause a low incidence of adverse cardiac effects." | 1.28 | Fluoxetine-induced bradycardia and syncope in two patients. ( Ellison, JM; Ely, E; Milofsky, JE, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores, DL | 1 |
| Alvarado, I | 1 |
| Wong, ML | 1 |
| Licinio, J | 1 |
| Flockhart, D | 1 |
| Grubb, BP | 3 |
| Wolfe, DA | 1 |
| Samoil, D | 3 |
| Temesy-Armos, P | 2 |
| Hahn, H | 1 |
| Elliott, L | 1 |
| Kosinski, D | 2 |
| Wolfe, D | 1 |
| Lorton, M | 1 |
| Madu, E | 1 |
| Akpunonu, B | 1 |
| Chin, CK | 1 |
| Roe, CJ | 1 |
| Thomas, GW | 1 |
| Azaz-Livshits, TL | 1 |
| Danenberg, HD | 1 |
| Roose, SP | 1 |
| Glassman, AH | 1 |
| Attia, E | 1 |
| Woodring, S | 1 |
| Giardina, EG | 1 |
| Bigger, JT | 1 |
| Montastruc, JL | 1 |
| Pelat, M | 1 |
| Verwaerde, P | 1 |
| Brefel-Courbon, C | 1 |
| Tran, MA | 1 |
| Blin, O | 1 |
| Rascol, O | 1 |
| Senard, JM | 1 |
| Roberts, RL | 1 |
| Joyce, PR | 1 |
| Mulder, RT | 1 |
| Begg, EJ | 1 |
| Kennedy, MA | 1 |
| Feder, R | 1 |
| Ellison, JM | 1 |
| Milofsky, JE | 1 |
| Ely, E | 1 |
| Downs, JM | 1 |
| Dahmer, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00265291] | Phase 2 | 700 participants (Actual) | Interventional | 1999-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for fluoxetine and Hypotension, Postural
| Article | Year |
|---|---|
Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension.
Topics: Aged; Female; Fluoxetine; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prospective Studies; | 1994 |
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
Topics: Aged; Aged, 80 and over; Animals; Blood Pressure; Denervation; Disease Models, Animal; Dogs; Female; | 1998 |
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; ATP Binding Casse | 2002 |
9 other studies available for fluoxetine and Hypotension, Postural
| Article | Year |
|---|---|
Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans.
Topics: Adult; Cytochrome P-450 CYP2D6; Depression; Desipramine; Double-Blind Method; Fluoxetine; Humans; Hy | 2004 |
Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.
Topics: Adult; Bradycardia; Drug Tolerance; Female; Fluoxetine; Humans; Hypotension, Orthostatic; Male; Post | 1993 |
The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing.
Topics: 1-Naphthylamine; Aged; Cardiac Pacing, Artificial; Carotid Sinus; Fluoxetine; Follow-Up Studies; Hea | 1994 |
Fluoxetine: a treatment option for severe symptomatic postural hypotension in a diabetic haemodialysis patient.
Topics: Diabetes Mellitus, Type 2; Fluoxetine; Humans; Hypotension, Orthostatic; Male; Middle Aged; Renal Di | 1996 |
Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Drug Interactions; Drug | 1997 |
Cardiovascular effects of fluoxetine in depressed patients with heart disease.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Blood Pressure; Comorbidity; Depressive Disorder; Dru | 1998 |
Bradycardia and syncope induced by fluoxetine.
Topics: Adult; Blood Pressure; Bradycardia; Depressive Disorder; Dose-Response Relationship, Drug; Female; F | 1991 |
Fluoxetine-induced bradycardia and syncope in two patients.
Topics: Adult; Bradycardia; Depressive Disorder; Female; Fluoxetine; Humans; Hypotension, Orthostatic; Synco | 1990 |
Fluoxetine and elevated plasma levels of tricyclic antidepressants.
Topics: Antidepressive Agents, Tricyclic; Drug Interactions; Female; Fluoxetine; Humans; Hypotension, Orthos | 1990 |